Skip to content

A clinical study on the ayurvedic management of enlarged adenoids in children using oral administration of shunthyadi churna and Nasal oil instillation

Efficacy of Shunthyadi Churna and Pratimarsha Nasya with Kalingadi taila in Kantha Shaluka,Adenoid Enlargement in children- An open labelled randomized controlled study - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/102231
Enrollment
34
Registered
2026-01-28
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J352- Hypertrophy of adenoids

Interventions

None listed

Sponsors

Dr Sharanubasu Mallappa Sajjan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Children aged between 5-10 years of either gender with clinical and neck radiographical features of Grade I- Grade III adenoid hypertrophy. 2. Willing to participate with informed parental consent

Exclusion criteria

Exclusion criteria: Children will be excluded from the study if they present with 1. Age below 5years or above 10 years. 2. Deviated nasal septum, nasal anatomical defect and other comorbidities like Nasal polyps or other sinonasal diseases 3. Known allergy or hypersensitivity to steroids 4. Children with an immunodeficiency condition 5. Grade IV adenoid hypertrophy

Design outcomes

Primary

MeasureTime frame
Clinically significant improvement in the symptoms of Kantha Shaluka, Adenoid Enlargement, based on symptomatic gradingTimepoint: 0th day Before treatment 14th day monitoring 29th day After treatment 36th day follow up

Secondary

MeasureTime frame
Clinically significant improvement and difference in the quality of life in children with Kantha Shaluka, adenoid enlargement based on OSA-18 quality of life survey. And to compare the efficacy of medicine in the trial group and the control group on Kantha Shaluka, Adenoid Enlargement using symptomatic grading and OSA-18 quality of life survey.Timepoint: 0th day Before treatment 14th day monitoring 29th day After treatment 36th day follow up

Countries

India

Contacts

Public ContactDr Sharanubasu Mallappa Sajjan

Shri Dharmastala Manjunatheshwara institute of ayurveda and hospital,Bangalore

srilakshmi.srinivas17@gmail.com8971263454

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026